BRENDON BOWER: Open Payments
NPI 1972070316 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$39,403 in 102 payments from 23 companies in 2025. Trend: 2023 $3,487 · 2024 $19,547 · 2025 $39,403
Speaker / faculty: $26,825Travel & lodging: $3,862Consulting: $3,688Food & beverage: $2,628Honoraria: $2,400
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 53 | $29,330 |
| Phathom Pharmaceuticals, Inc. | 3 | $3,810 |
| QOL Medical, LLC | 13 | $3,433 |
| Gilead Sciences, Inc. | 3 | $1,090 |
| ABBVIE INC. | 6 | $361 |
| Madrigal Pharmaceuticals | 3 | $229 |
| Novo Nordisk Inc | 1 | $125 |
| ViiV Healthcare Company | 1 | $123 |
| Amgen Inc. | 1 | $103 |
| Teva Pharmaceuticals USA, Inc. | 1 | $103 |
Products named: OMVOH, VOQUEZNA, Sucraid, Livdelzi, RINVOQ, REZDIFFRA, Wegovy, CABENUVA.
Industry payments across NY — which companies pay providers there.
